Bank of America
ENVB icon

Bank of America’s Enveric Biosciences ENVB Stock Holding History

Bank of America’s Portfolio ENVB Stock Details ENVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5
Closed -$18 – 6078
2025
Q4 		$18 Buy
5
+3
+150% +$20 ﹤0.01% 7140
2025
Q3 		$17 Hold
2
– – ﹤0.01% 8175
2025
Q2 		$29 Buy
+2
New +$30 ﹤0.01% 8195
2025
Q1 		– Sell
-1
Closed -$65 – 8370
2024
Q4 		$65 Hold
1
– – ﹤0.01% 7824
2024
Q3 		$82 Hold
1
– – ﹤0.01% 7751
2024
Q2 		$103 Hold
1
– – ﹤0.01% 7691
2024
Q1 		$100 Hold
1
– – ﹤0.01% 7394
2023
Q4 		$130 Hold
1
– – ﹤0.01% 7387
2023
Q3 		$238 Hold
1
– – ﹤0.01% 7394
2023
Q2 		$340 Hold
1
– – ﹤0.01% 7352
2023
Q1 		$166 Hold
1
– – ﹤0.01% 7444
2022
Q4 		$208 Hold
1
– – ﹤0.01% 7540
2022
Q3 		$0 Buy
+1
New +$1.26K ﹤0.01% 7933
2021
Q2 		– Hold
0
– – – 7822
2021
Q1 		– Hold
0
– – – 7505
2018
Q4 		– Hold
0
– -$4K – 7174
2018
Q3 		– Hold
0
– – – 6872

Other funds holding ENVB

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $208B AUM 16.12% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $41.5B AUM 29.19% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return

Bank of America's ENVB Position: Q1 2026 in Review

Bank of America sold out of Enveric Biosciences (ENVB) in Q1 2026, closing a stake of 5 shares — an estimated $18 sold.

Bank of America first reported a position in ENVB in Q3 2022 and held it in 13 quarters. The position peaked at $340 in Q2 2023. 11 funds tracked by Wall St. Rank hold ENVB as of Q1 2026.

  • Bank of America reported no remaining Enveric Biosciences position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 5 Enveric Biosciences shares in Q1 2026, an estimated $18.
  • Bank of America first reported a position in Enveric Biosciences in Q3 2022 and held it in 13 quarters.
  • Bank of America's Enveric Biosciences position peaked at $340 in Q2 2023.
  • 11 funds tracked by Wall St. Rank held Enveric Biosciences as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.